0

539267

SAMSRITA

img img img img
No Data Available

SAMSRITA LABS LIMITED Share Price Update

As of the latest trading session, SAMSRITA LABS LIMITED is trading at ₹15.41, down by ₹-0.79 or -4.87% from its previous close. The stock has moved between ₹15.40 and ₹16.50 today. Over the past year, the stock has delivered a return of -24.25%. In the last month, it has returned -9.34%.

Investment Returns

Over 1 Month -9.34% Over 3 Months -6.78% Over 6 Months -26.68% Over 1 Year -24.25%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SAMSRITA LABS LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 35.40
  • P/E Ratio (TTM) -4.27
  • Beta 0.02
  • Book Value / share 6.51
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -3.36
info icon alternate text

SAMSRITA LABS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 3.36
Net Profit -3.36
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.48
EBITDA -3.36
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 4.94
Net Profit -4.94
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -2.17
EBITDA -4.94
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.28
Net Profit -0.28
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.19
EBITDA -0.28
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.09
Net Profit -0.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.06
EBITDA -0.09
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.26
Net Profit -0.26
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.18
EBITDA -0.26
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.25
Net Profit -0.25
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.17
EBITDA -0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.02
Operating Expense 1.01
Net Profit -0.71
Net Profit Margin (%) -3550.00
Earnings Per Share (EPS) -0.48
EBITDA -0.71
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.02
Operating Expense 0.43
Net Profit 1.50
Net Profit Margin (%) 7500.00
Earnings Per Share (EPS) 1.01
EBITDA 1.51
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.01
Operating Expense 0.93
Net Profit -0.77
Net Profit Margin (%) -7700.00
Earnings Per Share (EPS) -0.42
EBITDA -0.76
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 8.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.19
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.17
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.45
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.19
EBITDA Margin -3500.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.93
ROE % 9.78
ROCE % 8.36
Total Debt to Total Equity 0.21
EBITDA Margin 7500.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 7.53
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.48
EBITDA Margin -7600.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 8.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.19
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.34
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.17
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.50
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.19
EBITDA Margin -3500.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.98
ROE % 9.58
ROCE % 8.21
Total Debt to Total Equity 0.20
EBITDA Margin 7500.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 7.97
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.17
EBITDA Margin -7600.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.56
Total Liabilities 15.56
Total Equity 11.97
Share Outstanding 1
Price to Book Ratio 1.72
Return on Assets (%) -1.82
Return on Capital (%) -1.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.55
Total Liabilities 15.55
Total Equity 12.25
Share Outstanding 1
Price to Book Ratio 1.78
Return on Assets (%) -1.68
Return on Capital (%) -1.81
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.56
Total Liabilities 15.56
Total Equity 12.52
Share Outstanding 1
Price to Book Ratio 2.63
Return on Assets (%) -4.54
Return on Capital (%) -4.85
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 17.12
Total Liabilities 17.12
Total Equity 13.22
Share Outstanding 1
Price to Book Ratio 3.17
Return on Assets (%) 8.68
Return on Capital (%) 9.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 16.57
Total Liabilities 16.57
Total Equity 11.15
Share Outstanding 1
Price to Book Ratio 5.48
Return on Assets (%) -4.65
Return on Capital (%) -5.72
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.67
Total Liabilities 15.67
Total Equity 12.08
Share Outstanding 1
Price to Book Ratio 1.72
Return on Assets (%) -1.65
Return on Capital (%) -1.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.63
Total Liabilities 15.63
Total Equity 12.34
Share Outstanding 1
Price to Book Ratio 1.78
Return on Assets (%) -1.59
Return on Capital (%) -1.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 15.63
Total Liabilities 15.63
Total Equity 12.59
Share Outstanding 1
Price to Book Ratio 2.63
Return on Assets (%) -4.51
Return on Capital (%) -4.81
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 17.20
Total Liabilities 17.20
Total Equity 13.29
Share Outstanding 1
Price to Book Ratio 3.17
Return on Assets (%) 8.71
Return on Capital (%) 9.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 17.22
Total Liabilities 17.22
Total Equity 11.80
Share Outstanding 1
Price to Book Ratio 5.48
Return on Assets (%) -4.46
Return on Capital (%) -5.44
Particulars MAR 2025 (Values in Cr)
Net Income -0.25
Cash from Operations -0.22
Cash from Investing 0.00
Cash from Financing 0.22
Net change in Cash 0.00
Free Cash Flow -0.22
Particulars MAR 2024 (Values in Cr)
Net Income -0.24
Cash from Operations -0.12
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.12
Particulars MAR 2023 (Values in Cr)
Net Income -0.70
Cash from Operations 0.66
Cash from Investing 0.00
Cash from Financing -0.66
Net change in Cash 0.00
Free Cash Flow 0.66
Particulars MAR 2022 (Values in Cr)
Net Income 1.49
Cash from Operations -0.39
Cash from Investing 0.00
Cash from Financing 0.40
Net change in Cash 0.00
Free Cash Flow -0.39
Particulars MAR 2021 (Values in Cr)
Net Income -0.62
Cash from Operations -0.34
Cash from Investing -0.22
Cash from Financing 0.54
Net change in Cash -0.01
Free Cash Flow -0.11
Particulars MAR 2025 (Values in Cr)
Net Income -0.25
Cash from Operations -0.22
Cash from Investing 0.00
Cash from Financing 0.22
Net change in Cash 0.00
Free Cash Flow -0.22
Particulars MAR 2024 (Values in Cr)
Net Income -0.24
Cash from Operations -0.12
Cash from Investing 0.00
Cash from Financing 0.12
Net change in Cash 0.00
Free Cash Flow -0.12
Particulars MAR 2023 (Values in Cr)
Net Income -0.70
Cash from Operations 0.66
Cash from Investing 0.00
Cash from Financing -0.66
Net change in Cash 0.00
Free Cash Flow 0.66
Particulars MAR 2022 (Values in Cr)
Net Income 1.49
Cash from Operations -0.39
Cash from Investing 0.00
Cash from Financing 0.40
Net change in Cash 0.00
Free Cash Flow -0.39
Particulars MAR 2021 (Values in Cr)
Net Income -0.62
Cash from Operations -0.34
Cash from Investing -0.22
Cash from Financing 0.54
Net change in Cash -0.01
Free Cash Flow -0.11
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AEGIS LOGISTICS LIMITED 686.15 31.30 4.05 24083.87 576.00 946.50
KOTHARI INDUSTRIAL CORP L 170.00 0.00 6.72 1836.37 152.00 624.95
OSWAL AGRO MILLS LTD 45.12 6.98 0.62 605.65 33.50 110.69
DHUNSERI VENTURES LIMITED 232.95 0.00 0.25 815.79 176.20 402.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AEGIS LOGISTICS LIMITED 686.15 37.35 8.75 24083.87 576.00 946.50
UTIQUE ENTERPRISES LIMITED 4.05 6.53 0.31 22.55 3.20 6.40
COMPUTER POINT LTD. 3.90 0.00 0.35 11.70 3.41 6.79
KOTHARI INDUSTRIAL CORP L 170.00 0.00 6.71 1836.37 152.00 624.95

SAMSRITA LABS LIMITED shareholding pattern

Holding
74.56%
25.43%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SAMSRITA LABS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
15.55 -4.07 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 16.00
  • 26 Days 16.50
  • 10 Days 16.20
  • 50 Days 16.90
  • 12 Days 16.20
  • 100 Days 17.70
  • 20 Days 16.40
  • 200 Days 18.70
15.78 PIVOT
First Support 15.31 First Resistance 16.67 Second Support 14.42 Second Resistance 17.14 Third Support 13.95 Third Resistance 18.03
RSI 48.20 ADX 9.90 MACD -0.24 Williams % R -44.56 Commodity Channel Index (CCI) -96.27
Date 2026-05-18 Week 10536.00 Same Day 2820.00 Month 4128.00
1 Year 0.02 3 Year 0.34
Over 1 Month
-9.34% down
Over 1 Year
-24.25% down
Over 3 Months
-6.78% down
Over 3 Years
-7.54% down
Over 6 Months
-26.68% down
Over 5 Years
-14.02% down

SAMSRITA LABS LIMITED Corporate Actions

Top Gainers

Top Losers

SAMSRITA LABS LIMITED Share Price

Samsrita Labs Limited was initially established as 'Dr Habeebullah Life Sciences Limited' on January 25, 1996. The name of the Company was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022. Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own. The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also.

In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.; Nutraceuticals product development; Trading, exporting and importing of medicinal drugs, chemicals, re-agents etc.

In 2016-17, the Company entered into a Collaborative Agreement with Krisani Bio Sciences Private Limited for further development of NASH (Fatty Liver) Molecule and Wilson Disease Molecule on revenue sharing basis and also entered into a Collaborative Agreement with Centre For liver Research And Diagnostics (CLRD) to use their land , building, equipment and other facilities to run their business of Hospital, Diagnostics, Pharmacy, Stem cell and other bio-technology laboratories on revenue sharing basis.

A diversified healthcare company with innovation is at the forefront of research and development in stem cells & regenerative medicine, new drug discovery, RNAi therapeutics, biomarker discovery. The Company was named after late Dr.CM Habeebullah, whose dedication and passion form the backbone of the Company's core values to provide affordable, world class cutting edge healthcare facilities to all. The Company has been established as an advanced center for research and excellence in areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi Specialty Hospital and CRO.

Krisani Bio Sciences Private Limited ceased to be the subsidiary of the Company with effect from 12.11.2021 and was made an Associate Company because of allotment of 64,00,000 equity shares at Rs. 10/- each by Krisani Bio Sciences Private Limited, erstwhile Subsidiary of the Company on a preferential basis and as a result the shareholding of the Company in Krisani Bio Sciences Private Limited came down from 51.33% to 32.91% in 2022.

During year 2024-25, the Board of Directors in the meeting held on 30.04.2025, altered the objects of the company by adding a new sub-clause including engaging in biofuels, food industry including processing, seeds, Green technologies, Information technology including deep technologies, logistics, e-commerce, Clinical research and allied activities and advisory services.

Parent organization Indian Private
NSE symbol [-]
Founded 1996
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Samsrita Labs Ltd?

Answer Field

Samsrita Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 15.55 as on May 19 2026 03:29 PM.

What is the Market Cap of Samsrita Labs Ltd Share?

Answer Field

The market cap of Samsrita Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 35.40 as on May 19 2026 03:29 PM.

What is the 52 Week High and Low of Samsrita Labs Ltd?

Answer Field

The 52 Week High and Low of Samsrita Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 26.04 and ₹ 13.78.

What is 1 year return for Samsrita Labs Ltd?

Answer Field

The 1 year returns on the stock has been -24.25%.

What is the P/E Ratio of Samsrita Labs Ltd Share?

Answer Field

As on May 19 2026 03:29 PM the price-to-earnings (PE) ratio for Samsrita Labs Ltd share is -4.27.

What is the PB ratio of Samsrita Labs Ltd Share?

Answer Field

As on May 19 2026 03:29 PM, the price-to-book (PB) ratio for Samsrita Labs Ltd share is 6.51.

How to Buy Samsrita Labs Ltd Share?

Answer Field

You can trade in Samsrita Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Samsrita Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Samsrita Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Samsrita Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|